We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADMS
776
DELISTED
Adamas Pharmaceuticals
ADMS
| $605K | 0.01% |
21,348
-47,500
| -69% | -$800K |
|
777
Wells Fargo
WFC
$264B
| $599K | 0.01% |
11,011
-433,230
| -98% | -$23.5M |
|
|
FL
778
DELISTED
Foot Locker
FL
| $597K | 0.01% |
+9,171
| New | +$610K |
|
779
Vulcan Materials
VMC
$36.9B
| $597K | 0.01% |
+6,282
| New | +$609K |
|
|
GWB
780
DELISTED
Great Western Bancorp, Inc.
GWB
| $597K | 0.01% |
20,567
-286,751
| -93% | -$8.16M |
|
|
CPLA
781
DELISTED
Capella Education Company
CPLA
| $586K | 0.01% |
12,678
+8,196
| +183% | +$395K |
|
782
Anika Therapeutics
ANIK
$287M
| $578K | 0.01% |
+15,141
| New | +$579K |
|
783
SM Energy
SM
$6.92B
| $575K | 0.01% |
29,246
-60,784
| -68% | -$1.85M |
|
|
FNSR
784
DELISTED
Finisar Corp
FNSR
| $574K | 0.01% |
39,501
-485,206
| -92% | -$6.01M |
|
785
PVH
PVH
$4.04B
| $569K | 0.01% |
7,730
-28,049
| -78% | -$2.48M |
|
786
Tidewater
TDW
$4.12B
| $568K | 0.01% |
+2,528
| New | +$891K |
|
787
McKesson
MCK
$101B
| $562K | 0.01% |
2,848
-1,463
| -34% | -$276K |
|
|
GWPH
788
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $562K | 0.01% |
+8,087
| New | +$659K |
|
|
SCMP
789
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $562K | 0.01% |
+32,525
| New | +$583K |
|
790
HUB Group
HUBG
$2.92B
| $552K | 0.01% |
+33,524
| New | +$625K |
|
|
EDR
791
DELISTED
Education Realty Trust Inc
EDR
| $545K | 0.01% |
+14,391
| New | +$515K |
|
|
DANG
792
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $545K | 0.01% |
75,795
+27,550
| +57% | +$190K |
|
793
Intercontinental Exchange
ICE
$84.4B
| $543K | 0.01% |
10,585
-324,370
| -97% | -$16.3M |
|
|
SHLM
794
DELISTED
Schulman (A.) Inc
SHLM
| $533K | 0.01% |
17,397
-48,181
| -73% | -$1.62M |
|
|
TE
795
DELISTED
TECO ENERGY INC
TE
| $531K | 0.01% |
19,906
-3,520
| -15% | -$94K |
|
|
GNC
796
DELISTED
GNC Holdings, Inc.
GNC
| $530K | 0.01% |
17,082
-192,974
| -92% | -$6.5M |
|
797
Enviri
NVRI
$620M
| $523K | ﹤0.01% |
+66,316
| New | +$648K |
|
|
RATE
798
DELISTED
Bankrate Inc
RATE
| $514K | ﹤0.01% |
+38,615
| New | +$510K |
|
799
Equinix
EQIX
$103B
| $507K | ﹤0.01% |
+1,677
| New | +$490K |
|
800
Neurogene
NGNE
$712M
| $506K | ﹤0.01% |
+2,027
| New | +$533K |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.